TACE With Dicycloplatin(TP21) in Unresectable HCC

Clinical trial NCT05472896 · UNKNOWN

Trial details

NCT number: NCT05472896
Sponsor: Gao-jun Teng
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-06-09
Primary completion: 2024-06-30
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.